Can omicron’s multiple subvariants outpace COVID tests, vaccines, and treatments?
Addressing the global pandemic resulting from the novel coronavirus, SARS-CoV-2, the resulting illness, COVID-19.
Explore the latest public health research and insights about COVID-19.
Looking for prominent public health experts in the field of COVID-19? They’re here at the Bloomberg School of Public Health.
Sabra Klein, PhD '98, studies sex differences and the effects of pregnancy on immune responses to viruses, including influenza viruses and SARS-Cov-2, and vaccines.